SCHEMBL7975233

SCHEMBL7975233

CC(C)(C)c1cc(OCc2ccccc2)ccc1C(Cl)C(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.47
▸ MAOB P27338 10/20 0.45
▸ LMNA P02545 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ PTGS1 P23219 1/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ PTGS2 P35354 1/20 0.42
▸ SLC6A3 Q01959 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ HRH3 Q9Y5N1 2/20 0.42
▸ MAOA P21397 3/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ TOP1 P11387 1/20 0.41
▸ MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989353 0.86 ALOX5 (0.45) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL24448850 0.78 ALOX5 (0.51) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL13021506 0.78 MAOB (0.56) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL21617280 0.78 MAOB (0.53) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL17481249 0.75 ALOX5 (0.51) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL6825691 0.74 MAOB (0.52) ALOX5MAOBMAOARAB9AMAPT
SCHEMBL10390637 0.72 CYP1A2 (0.44) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL27922861 0.72 CYP1A2 (0.55) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL27010416 0.72 ALOX5 (0.61) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL19660278 0.71 MAOB (0.52) ALOX5MAOBMAOARAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback